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Abstract An analysis of microarray data from 86 lung adeno-
carcinomas reveals hundreds of genes signi¢cantly correlated
with tumor cell di¡erentiation. A bioinformatics approach of
linking these genes to public information from the Locuslink
and KEGG databases yields evidence for a loss of tumor cell
di¡erentiation being associated with biological processes of cell
division, protein degradation, pyrimidine and purine metabolism,
oxidative phosphorylation, glyoxylate and dicarboxylate me-
tabolism, folate biosynthesis, and glutamate metabolism. The
increased expression of genes involved in these processes is con-
sistent with increased proliferation and metabolism charac-
teristics of poorly di¡erentiated tumors. The complete results
of this analysis are available at http://dot.ped.med.umich.edu:
2000/pub/di¡/index.htm.
) 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The loss of di¡erentiation in cancer cells, a process by
which the cells gradually lose the characteristics of their or-
gan-speci¢c tissue of origin, is a hallmark of the progression
of the disease, and tumor di¡erentiation status has prognostic
signi¢cance for recurrence and death in lung cancer [1]. In a
recent study by Beer et al. [2] that used global gene expression
pro¢les to predict lung cancer patient survival, hierarchical
clustering of pro¢les from lung tumors showed signi¢cant
di¡erences between the clusters with respect to di¡erentiation
status; as expected, lung tumors with similar di¡erentiation
clustered together. We have carried out a post-planned anal-
ysis of the Beer et al. dataset and have found numerous genes
signi¢cantly correlated in terms of their expression with the
level of tumor di¡erentiation, most of them with negative
correlations, i.e. the high expression of these genes being in-
dicative of a loss of di¡erentiation. While a list of hundreds of
genes by itself may shed little light on the processes involved
with a loss or gain of di¡erentiation in cancer, we have also
found, through linking the genes to public sources of gene
annotation and biological pathway information, key biologi-
cal features that appear signi¢cantly over-represented in the
set of negatively correlated genes, providing valuable insight
into and stimulating hypotheses surrounding the molecular
biology of lung cancer.
2. Materials and methods
2.1. Data collection
We obtained the dataset of A¡ymetrix HuGeneFL gene chip pro-
¢les from 86 primary lung adenocarcinomas, including 67 stage I and
19 stage III tumors, that was generated by the previous study by Beer
et al. [2]. The di¡erentiation status of each tumor pro¢led had been
established by a pathological assessment and consisted of a rating of
‘poor’, for poorly di¡erentiated (of which there were 21 tumors out
the 86 pro¢led), ‘moderate’, for moderately di¡erentiated (41 tumors),
or ‘well’, for well di¡erentiated (23 tumors).
2.2. Identi¢cation of genes signi¢cantly correlated with tumor
di¡erentiation
We assigned each pro¢led tumor a number based on the di¡eren-
tiation status, 31 for ‘poor’, 0 for ‘moderate’ and 1 for ‘well’ ; one of
the tumors had been rated as ‘moderate-to-well’ and received a value
of 0.5. We then calculated the Pearson correlation coe⁄cient between
the intensity values for each probe set and the numerical values for
di¡erentiation. The signi¢cance of the magnitude of any given coef-
¢cient was estimated using 1000 random permutations of the pro¢le
di¡erentiation labels to determine the likelihood distribution for the
dataset. We calculated the number of genes with signi¢cance values
less than 1032, less than 1033, and less than 1034 for the magnitude of
the correlation coe⁄cient being as high as it was for the gene by
chance.
2.3. Signi¢cantly enriched annotation terms and KEGG pathways
among gene sets
For the set of genes showing the lowest negative correlations with
tumor di¡erentiation status, a search was made for ‘signi¢cantly en-
riched’ annotation terms, i.e. terms that appear disproportionately in
the gene set to a signi¢cant extent. The same type of search was made
as well for the set of genes showing the highest positive correlations
with tumor di¡erentiation. GO terms and other external annotation
terms were obtained from the Locuslink database [3,4]. For a given
annotation term appearing n times in one of our sets of k genes, where
the term applied to a total of A genes out of the set of G unique genes
pro¢led on the HuGeneFL chip, the probability P for the term occur-
ring n or more times within a set of k genes randomly selected from
the chip was calculated using the hypergeometric formula:
As each annotation term in the Locuslink database (on the order of
2000) was tested for our set of genes of interest, the true signi¢cance
of a low P-value for an enriched term was estimated using 1000
Monte Carlo simulation tests, each test in which k genes were ¢rst
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randomly selected from the set of G genes, and P-values for the terms
occurring within the k set of genes were then calculated in order to
determine the likelihood distribution for the dataset. Although a sim-
pler Bonferroni correction of multiplying a P-value by the total num-
ber of annotation terms tested might have been used to estimate its
signi¢cance, the signi¢cance would then likely be greatly underesti-
mated, as the terms are not equally likely to be assigned a given
P-value (e.g. one term may be represented by 200 genes on the array
chip, while another term may be represented by only two genes).
Instead, for a P-value for a given term in a k set of genes calculated
using the hypergeometric formula, we estimated the number of terms
that would be expected to have a P-value lower than the given P-value
in a k set of randomly selected genes, by ¢rst counting the number of
occurrences within the set of 1000 simulation results in which any
term received a lower P-value and then dividing that number by 1000.
In order to identify signi¢cantly enriched pathways within the gene
sets, we carried out the same type of analysis described above using
the complete set of 119 biological pathways catalogued for Homo
sapiens in the KEGG encyclopedia [5]. Using the above hypergeomet-
ric formula, we calculated the probability P for n or more genes
belonging to a given pathway out of a set of k genes randomly se-
lected from the set of G genes pro¢led on the HuGeneFL chip, on
which A genes belonging to the pathway were represented. We carried
out 1000 Monte Carlo simulations as described above to determine
the true signi¢cance of an enriched pathway.
3. Results
3.1. Genes showing signi¢cant positive or negative correlations
with tumor di¡erentiation
Table 1 shows the number of probe sets that could be
considered signi¢cant at various signi¢cance levels for the
magnitude of the coe⁄cient of the correlation with tumor
di¡erentiation. Over 500 probe sets out of some 7029 on the
HuGeneFL chip had a signi¢cance value less than 0.001. Fig. 1
shows a histogram of the correlation to di¡erentiation for the
probe sets, along with an averaging of histograms generated
from 10 separate random permutations of the tumor di¡er-
entiation labels in the actual dataset, illustrating that the tails
of the distribution for the correlation coe⁄cients from the
actual dataset are much more spread out compared to the
distribution tails for the permutated datasets. Roughly twice
as many probe sets in the actual dataset show signi¢cant
negative correlations than show positive correlations. The
complete list of signi¢cant genes with respect to tumor di¡er-
entiation is available at our web site [12].
For our subsequent analysis for enriched annotation terms
and pathways, we selected the probe sets with an absolute
correlation coe⁄cient greater than 0.3, the choice of 0.3 as a
cuto¡ being somewhat arbitrary, but which included 812
probe sets, each with a signi¢cance value less than 0.0043.
From the 812 probe sets, we selected genes into two sets,
one set of 462 genes with mRNA expression showing negative
correlations with tumor di¡erentiation, and the other of 286
genes with mRNA expression showing positive correlations
with di¡erentiation (the remaining probe sets either did not
map to a known gene or referred to a gene that was pro¢led
by two or more probe sets).
3.2. Signi¢cantly enriched annotation terms for genes
correlated with loss of tumor di¡erentiation
We searched the set of genes positively correlated with dif-
ferentiation and the negatively correlated set of genes sepa-
rately for signi¢cantly enriched annotation terms (i.e. groups
of functionally related genes). Table 2 displays the most sig-
ni¢cant terms found for the set of negatively correlated genes,
which terms include RNA-binding protein, 26S proteasome,
nuclear-cytoplasmic transport, DNA synthesis, small nuclear
ribonucleoprotein, mitochondrial, ligase, protein folding, nuclear
pore, RNA splicing, DNA replication factor, protein degrada-
tion, and protein synthesis. If we consider the set of enriched
terms listed in Table 2 to be signi¢cant over any other terms
that could appear similarly enriched within a set of randomly
selected genes, then we may expect on the order of 0.36 of the
Table 2 terms to appear signi¢cant by chance.
While for the positively correlated genes, several enriched
annotation terms of interest were found with a P-value less
than 0.05, including GTPase activating protein, gas exchange,
hemoglobin, intercellular transport, cell-cell matrix adhesion,
cell adhesion, and positive control of cell proliferation, none
of these terms could individually be considered truly signi¢-
cant, based on the Monte Carlo simulation test results, as
multiple terms were tested (in a randomly selected set of 286
genes, on the order of one enriched term would be expected to
have a P-value as low or lower than the lowest P-value that
occurred in the actual 286 gene set). The complete set of
enriched terms found for both sets of genes, including specif-
ically which genes fall under which terms, is available at our
web site [12].
3.3. Signi¢cantly enriched KEGG pathways for genes
correlated with loss of tumor di¡erentiation
Similar to our search for signi¢cant annotation terms, we
searched both the positively correlated and the negatively cor-
related sets of genes separately for signi¢cantly enriched
KEGG pathways. Table 3 displays the most signi¢cant path-
ways found for the set of negatively correlated genes, which
pathways include proteasome, cell cycle, pyrimidine metabo-
lism, oxidative phosphorylation, glyoxylate and dicarboxylate
Table 1
The number of HuGeneFL probe sets found to be signi¢cantly cor-
related with tumor di¡erentiation in the Beer et al. [2] dataset, with
the approximate number of probe sets that may have a high abso-
lute correlation value by chance (Expected)
Signi¢cance Probe sets Expected
1034 266 1
1033 536 7
1032 1050 71
Fig. 1. Histogram of the correlation to di¡erentiation for the probe
sets in the lung tumor gene expression dataset from Beer et al. [2].
Also displayed is an averaging of histograms generated from 10 sep-
arate random permutations of the tumor di¡erentiation labels in the
original dataset.
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metabolism, folate biosynthesis, glutamate metabolism, one car-
bon pool by folate, purine metabolism, and aminoacyl-tRNA
biosynthesis. If we consider these pathways to be signi¢cant
over any other pathways that could appear similarly enriched
within a set of randomly selected genes, then we may expect
on the order of one of these pathways to appear signi¢cant by
chance. As with the search for annotation terms, no truly
signi¢cant pathways were found for the positively correlated
genes. The complete set of enriched pathways found for both
sets of genes, including which genes belong to which path-
ways, is available at our web site [12].
4. Discussion
The results of our analysis implicate on the order of hun-
dreds of genes as being involved with a loss of di¡erentiation
in cancer, either directly or through processes indirectly asso-
ciated with the progression of the disease. Furthermore, we
found numerous classes of genes, de¢ned by Locuslink anno-
tation or KEGG pathway, that appear disproportionately
within the set of genes showing the strongest negative corre-
lations with tumor di¡erentiation, to the extent that the ex-
pression of these genes is not likely to have resulted merely
from an overall deregulation of gene transcription within tu-
mor cells, but instead appears to be representative of a sys-
tematic up-regulation of several biological processes that can
be linked to a loss of di¡erentiation and an increase in cell
proliferation in tumors. Conversely, if there had been no sig-
ni¢cant classes found associated with the negatively correlated
genes, it might have been inferred that the genes as a whole
have no particular biological features that distinguish them
from any randomly selected set of genes. While DNA copy
number has recently been shown to have a major direct role in
the alteration of the transcriptome in cancer [6], the increased
expression of genes associated here with the progression of the
disease appears to represent more than the random ampli¢ca-
tion of individual genes irrespective of the processes in which
they participate, though amplicons may include genes such as
those that encode transcription factors, which can have sys-
tematic e¡ects.
Table 2
Signi¢cantly enriched annotation terms found for the set of 462 genes with signi¢cant negative correlations with tumor cell di¡erentiation (with
a coe⁄cient value less than 30.3 and a signi¢cance value less than 0.005)
Category Term Total Found P-value Expected
Biochemical function RNA-binding protein 114 30 1.56E-07 0
Biochemical function Proteasome subunit 30 14 1.58E-07 0
Cellular component 26S proteasome 32 14 4.27E-07 0
Cellular role Nuclear-cytoplasmic transport 20 9 4.07E-05 0.008
Cellular role DNA synthesis 51 15 5.24E-05 0.014
Molecular localization RNA-associated 121 26 5.55E-05 0.014
Subcellular localization Nuclear transport factor 4 4 8.36E-05 0.018
Subcellular localization Nuclear 476 70 0.000106 0.031
Molecular function Small nuclear ribonucleoprotein 10 6 0.000113 0.033
Subcellular localization Mitochondrial 149 29 0.000139 0.036
Biochemical function Ligase 33 11 0.000153 0.039
Biological process Protein folding 24 9 0.000223 0.046
Cellular component Nuclear pore 15 7 0.000232 0.048
Biological process Ubiquitin-dependent protein degradation 12 6 0.000421 0.107
Cellular role RNA splicing 37 11 0.000475 0.121
Cellular component Spindle 9 5 0.000721 0.157
Molecular function DNA replication factor 3 3 0.000877 0.189
Cellular role Protein degradation 106 21 0.000904 0.36
Cellular role Protein synthesis 128 24 0.000913 0.362
The number of occurrences for each term within the set of genes pro¢led on the HuGeneFL chip is listed, along with the number of genes
found in the set of 462 that fall under the term. The P-value for each term was calculated using the hypergeometric formula, and the number
of terms that could be expected to have a P-value less than the given P-value in a set of 462 randomly selected genes was calculated using sim-
ulation tests.
Table 3
Signi¢cantly enriched pathways found for the set of 462 genes with signi¢cant negative correlations with tumor cell di¡erentiation
KEGG id Category Title Total Found P-value Expected
hsa03050 Sorting and degradation Proteasome 24 14 4.83E-10 0.009
hsa04110 Cell growth and death Cell cycle 55 16 4.9E-06 0.01
hsa00240 Nucleotide metabolism Pyrimidine metabolism 50 15 6.38E-06 0.011
hsa00190 Energy metabolism Oxidative phosphorylation 55 14 9.85E-05 0.016
hsa00630 Carbohydrate metabolism Glyoxylate and dicarboxylate
metabolism
4 3 0.002071 0.116
hsa00790 Metabolism of cofactors and vitamins Folate biosynthesis 13 5 0.002707 0.19
hsa00251 Amino acid metabolism Glutamate metabolism 19 6 0.003202 0.219
hsa00670 Metabolism of cofactors and vitamins One carbon pool by folate 10 4 0.006332 0.42
hsa00230 Nucleotide metabolism Purine metabolism 88 14 0.01184 0.889
hsa00970 Transcription Aminoacyl-tRNA biosynthesis 18 5 0.012783 0.916
The number of genes that are pro¢led on the HuGeneFL chip for each pathway is listed, along with the number of genes found in the set of
462 that belong to the pathway. The P-value for each pathway was calculated using the hypergeometric formula, and the number of pathways
that could be expected to have a P-value less than the given P-value in a set of 462 randomly selected genes was calculated using simulation
tests.
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A set of signi¢cantly enriched gene classes being associated
with the genes showing the strongest positive correlations to
tumor di¡erentiation would be something of interest, as such
classes might implicate one or more processes as acting coun-
ter to the processes related to a loss of di¡erentiation. Though
the most enriched classes found here for the positively corre-
lated genes do make some sense from a biological standpoint
(e.g. for classes related to cell adhesion, a less di¡erentiated
cell may be less connected to its adjacent cells), none of these
classes could be considered strongly signi¢cant from a statis-
tical standpoint, especially compared to the signi¢cance of the
classes associated with the negatively correlated genes. This
fact might suggest that there are no genetic programs that
may become activated to keep the cell from becoming less
and less di¡erentiated, at least no known programs that could
adequately be described in terms of either the Locuslink an-
notations or the KEGG pathways.
One model that could help explain there being no well-de-
¢ned processes strongly associated with a gain of tumor di¡er-
entiation is that the loss of transcription of individual genes
normally expressed in the more di¡erentiated cells may be
indicative of the process of natural selection that can underlie
the progression of the disease [7], as genes that o¡er no com-
petitive advantage to a cancer cell may be selectively removed
from the transcriptome in a random manner, as in the case of
gene deletion. If a deleted gene happens to be a transcriptional
repressor, then the net e¡ect could be a systematic up-regu-
lation of the set of genes that would normally be repressed,
which may account in part for the observation made here of
many more genes being negatively correlated to tumor di¡er-
entiation than being positively correlated.
Taken together, the set of signi¢cantly enriched annotation
terms found for genes negatively correlated to di¡erentiation
are indicative of an overall process of increased cell prolifer-
ation and increased protein synthesis and degradation. This
¢nding helps con¢rm what should already be known, as cells
that are continuously dividing will lose the characteristics of a
di¡erentiated cell, and as protein degradation plays a critical
role in cell proliferation in cancer [8]. The observation of the
cell cycle and proteasome being included in the set of signi¢-
cant pathways reinforces the conclusions drawn from the set
of signi¢cant annotation terms. Other pathways that appear
signi¢cant may be indicative of the increased energy require-
ments of proliferating cells (e.g. oxidative phosphorylation),
but other signi¢cant pathways with links to cancer suggested
in previous studies may merit further investigation. In partic-
ular, glutamate antagonists have been shown to limit tumor
growth [9], and antimetabolites of purine and pyrimidine nu-
cleotide metabolism can cause many types of cancer cells to
terminally di¡erentiate into mature, non-proliferating cells
[10]. In addition, many studies suggest that the cellular level
of folate, which has a central role in biological methylation
and nucleotide synthesis, can modulate carcinogenesis [11].
Our study illustrates an exploratory approach of analyzing
global gene expression data by looking for known classes of
genes that appear over-represented within a set of genes of
interest, which can provide clues as to the types of processes
that underlie the expression of the genes and can stimulate
new hypotheses from which a directed study to address a
speci¢c question may follow.
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